Zydus Lifescience shares in focus on 4 observations from USFDA

Zydus Lifescience shares in focus on 4 observations from USFDA -

1) Zydus Lifescience share price will remain in focus on September 8 following the US regulator issued four observations to the company's Vadodara unit. 2) The United States Food and Drug Administration (USFDA) conducted an inspection at the group’s injectable manufacturing plant at Jarod, near Vadodara, Gujarat. 3) The US regulator issued four observations post completing inspection from August 25, to September 5, 2025, company said. 4) There were no data integrity related observations and will closely work with the USFDA to address the observations expeditiously, it added. 5) All this is for information. This is not a buy/sell recommendation. Thank you, Technofunda24